Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Michael Robert Martin net worth and biography

Michael Martin Biography and Net Worth

Insider of Aurinia Pharmaceuticals

Michael R. Martin serves as Chief Operating Officer of the Company. Michael Martin is currently COO of Aurinia Pharmaceuticals Inc. In this role he oversees all Business Development, Licensing and Partner Management activities along with overall management of the Company's intellectual property portfolio. Additionally, Michael is responsible for the executive leadership of Aurinia's ocular program. Michael was formerly CEO, director and co-founder of the privately held Aurinia Pharmaceuticals Inc., which merged in 2013 with the former Isotechnika Pharma Inc. Michael is a biotech/pharmaceutical executive with over 20 years of industry experience. Michael joined Aurinia from Vifor Pharma where he held the position of Director, Global Business Development & Licensing. Prior to Vifor, Michael was a key member of the business development team that saw Aspreva sold to Galenica for US$915M. Upon joining Aspreva in 2004, Michael initiated the strategic launch planning process for CellCept® in “less-common” autoimmune diseases. These included such indications as pemphigus vulgaris, myasthenia gravis, and lupus nephritis.

What is Michael Robert Martin's net worth?: The estimated net worth of Michael Robert Martin is at least $500,939.25 as of November 7th, 2022. Mr. Martin owns 55,475 shares of Aurinia Pharmaceuticals stock worth more than $500,939 as of December 22nd. This net worth evaluation does not reflect any other investments that Mr. Martin may own. Additionally, Mr. Martin receives an annual salary of $350,570.00 as Insider at Aurinia Pharmaceuticals. Learn More about Michael Robert Martin's net worth.
How old is Michael Robert Martin?: Mr. Martin is currently 52 years old. There are 5 older executives and no younger executives at Aurinia Pharmaceuticals. The oldest executive at Aurinia Pharmaceuticals is Mr. Scott Habig, Chief Commercial Officer, who is 64 years old. Learn More on Michael Robert Martin's age.
What is Michael Robert Martin's salary?: As the Insider of Aurinia Pharmaceuticals Inc., Mr. Martin earns $350,570.00 per year. There are 4 executives that earn more than Mr. Martin. The highest earning executive at Aurinia Pharmaceuticals is Mr. Peter S. Greenleaf M.B.A., President, CEO & Director, who commands a salary of $1,570,000.00 per year. Learn More on Michael Robert Martin's salary.
How do I contact Michael Robert Martin?: The corporate mailing address for Mr. Martin and other Aurinia Pharmaceuticals executives is 4464 MARKHAM STREET SUITE 1203, VICTORIA A1, V8Z 7X8. Aurinia Pharmaceuticals can also be reached via phone at 250-708-4272 and via email at [email protected]. Learn More on Michael Robert Martin's contact information.
Has Michael Robert Martin been buying or selling shares of Aurinia Pharmaceuticals?: Michael Robert Martin has not been actively trading shares of Aurinia Pharmaceuticals within the last three months. Most recently, Michael Robert Martin sold 40,000 shares of the business's stock in a transaction on Thursday, November 11th. The shares were sold at an average price of $29.01, for a transaction totalling $1,160,400.00. Learn More on Michael Robert Martin's trading history.
Who are Aurinia Pharmaceuticals' active insiders?: Aurinia Pharmaceuticals' insider roster includes Matthew Donley (VP), Peter Greenleaf (CEO), Robert Huizinga (EVP), Jill Leversage (Director), Michael Martin (Insider), Joseph Miller (CFO), and Neil Solomons (Insider). Learn More on Aurinia Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Aurinia Pharmaceuticals?: In the last twelve months, insiders at the biotechnology company sold shares 2 times. They sold a total of 22,806 shares worth more than $135,317.70. The most recent insider tranaction occured on November, 11th when Director Jeffrey Allen Bailey sold 4,557 shares worth more than $38,415.51. Insiders at Aurinia Pharmaceuticals own 4.3% of the company. Learn More about insider trades at Aurinia Pharmaceuticals.
Information on this page was last updated on 11/11/2024.

Michael Robert Martin Insider Trading History at Aurinia Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2021	Sell	40,000	$29.01	$1,160,400.00
11/9/2021	Sell	50,000	$30.17	$1,508,500.00
9/21/2021	Sell	87,500	$24.02	$2,101,750.00
9/14/2021	Sell	90,000	$21.19	$1,907,100.00
9/10/2021	Sell	25,000	$19.80	$495,000.00
8/9/2021	Sell	5,000	$16.01	$80,050.00
7/28/2021	Sell	5,000	$13.86	$69,300.00	211,861
6/22/2021	Sell	5,000	$13.76	$68,800.00	216,861

Michael Robert Martin Buying and Selling Activity at Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Company Overview

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Today's Range

Now: $9.03

$8.92

$9.23

50 Day Range

MA: $8.27

$6.99

$10.44

2 Week Range

Now: $9.03

$4.71

$10.67

Volume

1,584,323 shs

Average Volume

1,600,504 shs

Market Capitalization

$1.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

First JFK… next Elon?

From Porter & Company | Ad

I share with you in this special investigative documentary.

Michael Martin Biography and Net Worth

What is Michael Robert Martin's net worth?

How old is Michael Robert Martin?

What is Michael Robert Martin's salary?

How do I contact Michael Robert Martin?

Has Michael Robert Martin been buying or selling shares of Aurinia Pharmaceuticals?

Who are Aurinia Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Aurinia Pharmaceuticals?